Module date/time: Wednesday, July 25, 8:30 a.m.-5 p.m.
This module has two key segments. In the morning, two topics will be discussed that have broad implications in the design and analysis of clinical trials: the role of biomarkers as replacement (i.e., surrogate) endpoints, and the interpretability of confirmatory vs. exploratory analyses. In the afternoon, attention will be given to a topic having broad implications in the conduct of clinical trials: the role of Data Monitoring Committees and current challenges in their implementation.
Access 2017 Course Materials (2018 materials will be uploaded to this page prior to the start of the module)